Connect your AI

Evommune EVMN Common Stock Convertible Conversion Price Increase

Common Stock Convertible Conversion Price Increase at other companies

Quantum Computing Inc.QUBT

$5.00—

Evommune EVMN

$0.10—

Corvex MOVE

$136,364.00—

Evommune EVMN

$0.09—

Evommune EVMN

50%—

Evommune EVMN

25%—

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:CommonStockConvertibleConversionPriceIncrease.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's common stock convertible conversion price increase.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's common stock convertible conversion price increase?: Evommune (EVMN) reported common stock convertible conversion price increase of $0.10 in Q4 2025.
What does common stock convertible conversion price increase mean?: Reflects an upward adjustment in the conversion price for convertible debt or preferred equity, which reduces the potential dilution impact upon conversion. This is generally favorable for existing shareholders as it requires more equity to be issued for the same amount of debt or preferred capital.